{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:07:04Z","timestamp":1793300824542,"version":"4.5.0"},"reference-count":89,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>The paradigm shift toward precision oncology in advanced breast cancer has increased therapeutic complexity, prolonging survival for many patients while simultaneously expanding the temporal burden associated with cancer care. Time toxicity, defined as the cumulative time spent receiving, accessing, coordinating, and recovering from medical interventions, is increasingly recognized as a clinically meaningful but still under-assessed dimension of patient-centered value. Beyond its organizational and economic implications, time toxicity may exert profound psychological and psychiatric effects, particularly in patients with advanced disease, for whom time represents not only a practical resource but also an existential, relational, and emotional domain. This narrative review examines how objective and subjective dimensions of time toxicity may inform patient-centered decision-making in advanced breast cancer. We summarize current evidence on the temporal demands of cancer care in advanced breast cancer and their psychological and relational consequences, focusing on how these factors can be discussed in patient-centered treatment decisions. From a value-based oncology perspective, the review examines how treatment optimization, subcutaneous formulations, oral therapies, telemedicine-based surveillance, decentralized care models, and early psycho-oncological assessment may reduce non-value-added time in clinical settings while preserving quality of care. Methodological challenges in measuring time toxicity and correlating it with overall survival, health-related quality of life, anxiety, depression, demoralization, and illness-related distress are also discussed. Incorporating time toxicity into shared decision-making may help clinicians move beyond traditional efficacy endpoints. It may support a more comprehensive approach in which survival benefit, psychological well-being, personal priorities, and the subjective value of time are considered together.<\/jats:p>","DOI":"10.3390\/medicina62081551","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T12:53:48Z","timestamp":1786539228000},"page":"1551","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Time Toxicity in Advanced Breast Cancer: Psychological Burden, Psychiatric Vulnerability, and Implications for Patient-Centered Decision-Making"],"prefix":"10.3390","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7058-4927","authenticated-orcid":false,"given":"Giuseppe","family":"Marano","sequence":"first","affiliation":[{"name":"Department of Neuroscience, Head-Neck and Chest, Section of Psychiatry, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo Agostino Gemelli 8, 00168 Rome, Italy"},{"name":"Department of Neuroscience, Section of Psychiatry, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7445-3366","authenticated-orcid":false,"given":"Ida","family":"Paris","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6558-2932","authenticated-orcid":false,"given":"Gianandrea","family":"Traversi","sequence":"additional","affiliation":[{"name":"Unit of Medical Genetics, Department of Laboratory Medicine, Ospedale Isola Tiberina-Gemelli Isola, 00186 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osvaldo","family":"Mazza","sequence":"additional","affiliation":[{"name":"Spine Surgery Department, Bambino Ges\u00f9 Children\u2019s Hospital IRCCS, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Rotondaro","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"D\u2019Angelo","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9959-4360","authenticated-orcid":false,"given":"Paola","family":"Fuso","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0130-6584","authenticated-orcid":false,"given":"Daniela Pia Rosaria","family":"Chieffo","sequence":"additional","affiliation":[{"name":"Clinical Psychology Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo Francesco Vito 1, 00168 Rome, Italy"},{"name":"Department Women Children and Public Health, Universit\u00e0 Cattolica del Sacro Cuore, 20123 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2950-3395","authenticated-orcid":false,"given":"Gianluca","family":"Franceschini","sequence":"additional","affiliation":[{"name":"Breast Surgery Unit, Department of Woman and Child\u2019s Health and Public Health Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy"},{"name":"Department of Medical and Surgical Sciences, Catholic University of the Sacred Heart, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3007-8162","authenticated-orcid":false,"given":"Marianna","family":"Mazza","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Head-Neck and Chest, Section of Psychiatry, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo Agostino Gemelli 8, 00168 Rome, Italy"},{"name":"Department of Neuroscience, Section of Psychiatry, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","article-title":"Breast cancer","volume":"5","author":"Harbeck","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.annonc.2021.09.019","article-title":"ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer","volume":"32","author":"Gennari","year":"2021","journal-title":"Ann. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"103756","DOI":"10.1016\/j.breast.2024.103756","article-title":"6th and 7th International consensus guidelines for the management of advanced breast cancer","volume":"76","author":"Cardoso","year":"2024","journal-title":"Breast"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1200\/JCO.21.02810","article-title":"The time toxicity of cancer treatment","volume":"40","author":"Gupta","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/oncolo\/oyae187","article-title":"Patients\u2019 considerations of time toxicity when assessing cancer treatments with marginal benefit","volume":"29","author":"Gupta","year":"2024","journal-title":"Oncologist"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e859","DOI":"10.1200\/OP.22.00737","article-title":"Evaluating the time toxicity of cancer treatment in the CCTG CO.17 trial","volume":"19","author":"Gupta","year":"2023","journal-title":"JCO Oncol. Pract."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1200\/OP-24-00526","article-title":"Time toxicity of systemic anticancer therapy for metastatic lung cancer in routine clinical practice: A nationwide cohort study","volume":"21","author":"Ording","year":"2025","journal-title":"JCO Oncol. Pract."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"450","DOI":"10.6004\/jnccn.2023.0026","article-title":"NCCN Guidelines\u00ae Insights: Distress Management, Version 2.2023","volume":"21","author":"Riba","year":"2023","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"151555","DOI":"10.1016\/j.soncn.2023.151555","article-title":"Distress and psycho-oncological support for patients with advanced breast cancer","volume":"40","author":"Travado","year":"2024","journal-title":"Semin. Oncol. Nurs."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Marano, G., Paris, I., Traversi, G., Mazza, O., Pavese, F., D\u2019Angelo, T., Franceschini, G., and Mazza, M. (2026). Modern Personalized Strategies for Breas Cancer Treatment: Bridging Precision Oncology and Psycho-Oncology. J. Clin. Med., 15.","DOI":"10.3390\/jcm15041574"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Bure\u0161ov\u00e1, I., Kv\u011bton, P., Jel\u00ednek, M., Hal\u00e1mkov\u00e1, J., Kiss, I., Hrn\u010di\u0159\u00edkov\u00e1, I., and Kapounkov\u00e1, K. (2026). Psychophysiological changes during breast cancer treatment: A longitudinal analysis of subjective and objective indicators. BMC Womens Health, Epub ahead of printing.","DOI":"10.1186\/s12905-026-04565-1"},{"key":"ref_12","first-page":"146","article-title":"\u201c\u2026it is not the sickness itself that kills. It is the emotional trauma\u201d: A qualitative study of the lived experience and systemic barriers of women with breast cancer in Nigeria","volume":"34","author":"Asuquo","year":"2026","journal-title":"Support. Care Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","article-title":"SANRA\u2014A scale for the quality assessment of narrative review articles","volume":"4","author":"Baethge","year":"2019","journal-title":"Res. Integr. Peer Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"100610","DOI":"10.1016\/j.apjon.2024.100610","article-title":"Time toxicity in cancer care: A concept analysis using Walker and Avant\u2019s method","volume":"11","author":"Nwozichi","year":"2024","journal-title":"Asia Pac. J. Oncol. Nurs."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1200\/OP-24-01085","article-title":"A fifth of their days: The time commitments of advanced cancer and its care","volume":"21","author":"Johnson","year":"2025","journal-title":"JCO Oncol. Pract."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"100121","DOI":"10.1016\/j.esmorw.2025.100121","article-title":"Health care policies, drug costs, and time toxicities in biologics for HER2-positive breast cancer: Cost minimization analysis of direct and indirect costs","volume":"8","author":"Low","year":"2025","journal-title":"ESMO Real. World Data Digit. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1007\/s11864-025-01358-w","article-title":"Characterizing and Addressing the Financial, Time, and Administrative Burdens of Cancer and its Care","volume":"26","author":"Lin","year":"2025","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/cncr.35075","article-title":"Efficacy-effectiveness gaps in oncology: Looking beyond survival","volume":"130","author":"Wilson","year":"2024","journal-title":"Cancer"},{"key":"ref_20","first-page":"812","article-title":"The experience of time toxicity among patients with advanced cancer: A qualitative study","volume":"33","author":"Jing","year":"2025","journal-title":"Support. Care Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e70021","DOI":"10.1002\/pon.70050","article-title":"Scanxiety and fear of recurrence in young adult female survivors of breast and gynaecological cancers","volume":"33","author":"Patel","year":"2024","journal-title":"Psychooncology"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Calderon, C., Carmona-Bayonas, A., Hern\u00e1ndez, R., Castelo, B., Beato, C., and Jim\u00e9nez-Fonseca, P. (2024). Fear of recurrence in advanced cancer patients. Cancers, 16.","DOI":"10.3390\/cancers16050909"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e2547930","DOI":"10.1001\/jamanetworkopen.2025.47930","article-title":"Time toxicity of cancer care\u2014A call to action","volume":"8","author":"Doshi","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/NCC.0b013e31820f4eb7","article-title":"Time perception of cancer patients without evidence of disease and advanced cancer patients in a palliative, end-of-life-care setting","volume":"34","author":"Schilderman","year":"2011","journal-title":"Cancer Nurs."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e14486","DOI":"10.7717\/peerj.14486","article-title":"The rhythm of chemotherapy and cancer patients\u2019 time perspectives","volume":"10","author":"Moskalewicz","year":"2022","journal-title":"PeerJ"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"98271","DOI":"10.12998\/wjcc.v13.i16.98271","article-title":"Territories of mourning: Addressing submerged problems of grief through multidisciplinary care","volume":"13","author":"Marano","year":"2025","journal-title":"World J. Clin. Cases"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.genhosppsych.2025.02.023","article-title":"Existential distress in advanced cancer: A cohort study","volume":"94","author":"Philipp","year":"2025","journal-title":"Gen. Hosp. Psychiatry"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"651","DOI":"10.4143\/crt.2022.116","article-title":"Psychological aspects of care in cancer patients in the last weeks\/days of life","volume":"54","author":"Bruera","year":"2022","journal-title":"Cancer Res. Treat."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Kolsteren, E.E.M., Deuning-Smit, E., Chu, A.K., van der Hoeven, Y.C.W., Prins, J.B., van der Graaf, W.T.A., van Herpen, C.M.L., van Oort, I.M., Lebel, S., and Thewes, B. (2022). Psychosocial aspects of living long term with advanced cancer and ongoing systemic treatment: A scoping review. Cancers, 14.","DOI":"10.3390\/cancers14163889"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1017\/S1478951522001675","article-title":"Existential distress and meaning making among female breast cancer patients with cancer-related fertility concerns","volume":"21","author":"Carr","year":"2023","journal-title":"Palliat. Support. Care"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1177\/08982643211063162","article-title":"Experience of Time and Subjective Age When Facing a Limited Lifetime: The Case of Older Adults with Advanced Cancer","volume":"34","author":"Laryionava","year":"2022","journal-title":"J. Aging Health"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"100258","DOI":"10.1016\/j.tipsro.2024.100258","article-title":"Time estimation is associated with the levels of distress in patients prior to starting radiotherapy","volume":"31","author":"Zhelev","year":"2024","journal-title":"Tech. Innov. Patient Support Radiat. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Mazza, M., Biondi-Zoccai, G., Lisci, F.M., Brisi, C., Sfratta, G., Rossi, S., Traversi, G., Gaetani, E., Pola, R., and Morini, S. (2024). The Brain-Heart Axis: An Umbrella Review on Impact of Psychiatric Disease on Incidence, Management, and Outlook of Cardiovascular Disease. Life, 14.","DOI":"10.3390\/life14080919"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Tao, L., Wang, J., Zhang, H., Zhang, Y., Li, Y., and Zhang, J. (2024). Incidence and risk factors for psychological distress in adult female patients with breast cancer: A systematic review and meta-analysis. Front. Psychiatry, 15.","DOI":"10.3389\/fpsyt.2024.1309702"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1038\/s41380-020-00865-6","article-title":"Prognostic value of depression and anxiety on breast cancer recurrence and mortality: A systematic review and meta-analysis of 282,203 patients","volume":"25","author":"Wang","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s12160-011-9333-6","article-title":"History of major depressive disorder prospectively predicts worse quality of life in women with breast cancer","volume":"43","author":"Jim","year":"2012","journal-title":"Ann. Behav. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.3748\/wjg.v29.i45.5945","article-title":"Gut microbiota in women: The secret of psychological and physical well-being","volume":"29","author":"Marano","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Marano, G., Rossi, S., Sfratta, G., Traversi, G., Lisci, F.M., Anesini, M.B., Pola, R., Gasbarrini, A., Gaetani, E., and Mazza, M. (2025). Gut Microbiota: A New Challenge in Mood Disorder Research. Life, 15.","DOI":"10.3390\/life15040593"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Meijer, A., Roseman, M., Milette, K., Coyne, J.C., Stefanek, M.E., Ziegelstein, R.C., Arthurs, E., Leavens, A., Palmer, S.C., and Stewart, D.E. (2011). Depression screening and patient outcomes in cancer: A systematic review. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0027181"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12955-021-01816-7","article-title":"The effect of fear of progression on quality of life among breast cancer patients: The mediating role of social support","volume":"19","author":"Ban","year":"2021","journal-title":"Health Qual. Life Outcomes"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"He, J.L., Luo, B.M., Hu, Y., Qin, Z.F., Zheng, Q., Fan, L.H., Huang, X., Deng, Y.T., Zheng, Y., and Peng, M.S. (2023). Fear of disease progression among breast cancer patients in mainland China: A meta-analysis and systematic review. Front. Psychol., 14.","DOI":"10.3389\/fpsyg.2023.1222798"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"110634","DOI":"10.1016\/j.clinimag.2025.110634","article-title":"Prevalence, severity, and modifiable predictors of scanxiety in patients undergoing routine oncologic imaging: A prospective longitudinal study","volume":"128","author":"Shah","year":"2025","journal-title":"Clin. Imaging"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"102227","DOI":"10.1016\/j.cpr.2022.102227","article-title":"Clinical utility of demoralization: A systematic review of the literature","volume":"99","author":"Cosci","year":"2023","journal-title":"Clin. Psychol. Rev."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"100803","DOI":"10.1016\/j.apjon.2025.100803","article-title":"Demoralization and dignity loss in breast cancer: A network analysis and computer simulation study","volume":"12","author":"Xiong","year":"2025","journal-title":"Asia Pac. J. Oncol. Nurs."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"100811","DOI":"10.1016\/j.apjon.2025.100811","article-title":"Dyadic associations of cancer-related communication, family resilience, and demoralization in patients with gynecological cancer and their spouses: An actor-partner interdependence model","volume":"12","author":"Zhang","year":"2025","journal-title":"Asia Pac. J. Oncol. Nurs."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"102778","DOI":"10.1016\/j.ejon.2025.102778","article-title":"Decision fatigue among cancer patients with recurrence: A qualitative study","volume":"75","author":"Kang","year":"2025","journal-title":"Eur. J. Oncol. Nurs."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"121307","DOI":"10.1016\/j.jad.2026.121307","article-title":"Affective morbidity after cancer diagnosis: Nationwide incidence and pharmacotherapy patterns across five major cancer types","volume":"401","author":"Shin","year":"2026","journal-title":"J. Affect. Disord."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Marano, G., Paris, I., Traversi, G., Mazza, O., Migliore, A., Ricozzi, V., Rotondaro, S., Pavese, F., D\u2019Angelo, T., and Fuso, P. (2026). Insomnia in breast cancer: A neglected symptom cluster. J. Clin. Med., 15.","DOI":"10.3390\/jcm15124603"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Milic, J., Vucurovic, M., Grego, E., Jovic, D., Sapic, R., Jovic, S., and Jovanovic, V. (2025). From Fear to Hope: Understanding Preparatory and Anticipatory Grief in Women with Cancer-A Public Health Approach to Integrating Screening, Compassionate Communication, and Psychological Support Strategies. J. Clin. Med., 14.","DOI":"10.3390\/jcm14113621"},{"key":"ref_50","first-page":"275","article-title":"Reporting time toxicity in prospective cancer clinical trials: A scoping review","volume":"32","author":"Quinn","year":"2024","journal-title":"Support. Care Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e255033","DOI":"10.1001\/jamanetworkopen.2025.5033","article-title":"Health care contact days and outcomes in clinical trials vs routine care among patients with non-small cell lung cancer","volume":"8","author":"Gupta","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"ref_52","first-page":"144","article-title":"Time toxicity associated with treatment of metastatic or unresectable gastro-oesophageal cancers in the second-line setting","volume":"34","author":"Nguyen","year":"2026","journal-title":"Support. Care Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.clml.2024.02.013","article-title":"Financial Toxicity, Time Toxicity, and Quality of Life in Multiple Myeloma","volume":"24","author":"Banerjee","year":"2024","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1016\/0959-8049(95)00296-0","article-title":"The EORTC core quality of life questionnaire (QLQ-C30): Validity and reliability when analysed with patients treated with palliative radiotherapy","volume":"31","author":"Kaasa","year":"1995","journal-title":"Eur. J. Cancer"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/jamaoncol.2015.2639","article-title":"Validity and reliability of the US National Cancer Institute\u2019s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events","volume":"1","author":"Dueck","year":"2015","journal-title":"JAMA Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e2516762","DOI":"10.1001\/jamanetworkopen.2025.16762","article-title":"Telehealth and health care contact days among patients with advanced cancer after COVID-19","volume":"8","author":"Duffens","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Marano, G., Acanfora, M., Mandracchia, G., Traversi, G., Mazza, O., Pallotti, A., Veneziani, G., Lai, C., Caroppo, E., and Mazza, M. (2026). Digital and Immersive Technologies for Rehabilitation in Complex Psychosis: State of the Art and Future Directions. Medicina, 62.","DOI":"10.3390\/medicina62040765"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.3332\/ecancer.2025.1957","article-title":"Time toxicity in cancer treatment: Oncologists\u2019 knowledge and practices across Pakistan","volume":"19","author":"Hameed","year":"2025","journal-title":"Ecancermedicalscience"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1056\/NEJMoa2114663","article-title":"Overall survival with ribociclib plus letrozole in advanced breast cancer","volume":"386","author":"Hortobagyi","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ejca.2021.03.047","article-title":"Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study","volume":"152","author":"Sousa","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2203690","article-title":"Trastuzumab deruxtecan in previously treated HER2-low advanced breast cancer","volume":"387","author":"Modi","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa2028485","article-title":"Sacituzumab govitecan in metastatic triple-negative breast cancer","volume":"384","author":"Bardia","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e70001","DOI":"10.1111\/eci.70001","article-title":"Adverse events and impact on quality of life of antibody-drug conjugates in the treatment of metastatic breast cancer: A systematic review and meta-analysis","volume":"55","author":"Perachino","year":"2025","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Asad, A.H., Chaudhary, A., Raut, A., Kherodkar, J.P., Kaushik, P., and Katkar, S.R. (2026). Assessment of health-related quality of life in breast cancer patients undergoing chemotherapy at a tertiary care center in India. J. Oncol. Pharm. Pract., 10781552261445608.","DOI":"10.1177\/10781552261445608"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0140-6736(20)32531-9","article-title":"Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): A randomised, placebo-controlled, double-blind, phase 3 clinical trial","volume":"396","author":"Cortes","year":"2020","journal-title":"Lancet"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa2202809","article-title":"Pembrolizumab plus chemotherapy in advanced triple-negative breast cancer","volume":"387","author":"Cortes","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"oyag035","DOI":"10.1093\/oncolo\/oyag035","article-title":"Prognostic disclosure in metastatic breast cancer: A scoping review","volume":"31","author":"Battistuzzi","year":"2026","journal-title":"Oncologist"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/0272989X251379888","article-title":"Patient and Physician Perspectives on Using Risk Prediction to Support Breast Cancer Surveillance Decision Making","volume":"46","author":"Gunn","year":"2026","journal-title":"Med. Decis. Mak."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1200\/JCO.2017.75.2311","article-title":"Patient-clinician communication: American Society of Clinical Oncology consensus guideline","volume":"35","author":"Gilligan","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1200\/JCO-26-00118","article-title":"Patient-clinician communication: ASCO guideline update","volume":"44","author":"Gilligan","year":"2026","journal-title":"J. Clin. Oncol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Verbeke, C., Lievens, Y., Wildiers, H., Neven, P., Han, S.N., Floris, G., Van Herck, Y., Sermeus, W., Fieuws, S., and van de Poll-Franse, L.V. (2025). Patient preferences in breast cancer: A scoping review. Cancers, 17.","DOI":"10.3390\/cancers18010134"},{"key":"ref_72","first-page":"115916","article-title":"What matters most? Understanding patient preferences in breast cancer treatment decision-making: A systematic review of discrete choice experiments","volume":"236","author":"Chua","year":"2025","journal-title":"Am. J. Surg."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Lopez-Fernandez, O., Mestre-Bach, G., Labourdette, C., Gudayol-Ferr\u00e9, E., G\u00f3mez-Mart\u00ednez, M., and Mora-Maltas, B. (2025). The implementation of shared decision-making using patient decision aids in medical treatment choices for breast cancer: A scoping review. Healthcare, 13.","DOI":"10.3390\/healthcare13070748"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Prabhakaran, A., Mathias, E.G., Sathiyamoorthy, R., Bebarta, N.K., Lewis, S., and Rao, A.P. (2026). Caring for the caregivers: Breast and cervical cancer screening among informal caregivers of cancer patients\u2014A scoping review. BMC Prim. Care, Online ahead of print.","DOI":"10.1186\/s12875-026-03333-2"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1080\/08870446.2019.1584672","article-title":"Patient-provider care goal concordance: Implications for palliative care decisions","volume":"34","author":"Ellis","year":"2019","journal-title":"Psychol. Health"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e1935","DOI":"10.1200\/OP.21.00118","article-title":"Improving Outpatient Infusion Clinic Wait Times at a Comprehensive Cancer Center","volume":"17","author":"Sasankan","year":"2021","journal-title":"JCO Oncol. Pract."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.2017.7156","article-title":"Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment","volume":"318","author":"Basch","year":"2017","journal-title":"JAMA"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMoa1000678","article-title":"Early palliative care for patients with metastatic non-small-cell lung cancer","volume":"363","author":"Temel","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_79","first-page":"CD011129","article-title":"Early palliative care for adults with advanced cancer","volume":"6","author":"Haun","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1002\/cncr.31539","article-title":"Individual meaning-centered psychotherapy for the treatment of psychological and existential distress: A randomized controlled trial in patients with advanced cancer","volume":"124","author":"Breitbart","year":"2018","journal-title":"Cancer"},{"key":"ref_81","first-page":"1","article-title":"Profiles of posttraumatic stress disorder and posttraumatic growth among breast cancer patients: Role of caregiver burden","volume":"7","author":"Cao","year":"2026","journal-title":"Psychol. Health Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3390\/curroncol29010018","article-title":"Equity-Oriented Healthcare: What It Is and Why We Need It in Oncology","volume":"29","author":"Horrill","year":"2022","journal-title":"Curr. Oncol."},{"key":"ref_83","first-page":"437","article-title":"\u201cThe Cancer is My Life\u201d: Patient and caregiver perceptions of healthcare contact time in advanced cancer","volume":"33","author":"Stevens","year":"2025","journal-title":"Support. Care Cancer"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.annonc.2019.10.027","article-title":"An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45","volume":"31","author":"Cardoso","year":"2020","journal-title":"Ann. Oncol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s41687-024-00824-7","article-title":"Time to deterioration of patient-reported outcome endpoints in cancer clinical trials: Targeted literature review and best practice recommendations","volume":"8","author":"Cocks","year":"2024","journal-title":"J. Patient-Rep. Outcomes"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.annonc.2025.04.006","article-title":"ESMO-Magnitude of Clinical Benefit Scale version 2.0","volume":"36","author":"Cherny","year":"2025","journal-title":"Ann. Oncol."},{"key":"ref_87","first-page":"e2400200","article-title":"ENABLE\u2014App-based digital capture and intervention of patient-reported quality of life, adverse events, and treatment satisfaction in breast cancer","volume":"9","author":"Deutsch","year":"2025","journal-title":"JCO Clin. Cancer Inform."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e2527403","DOI":"10.1001\/jamanetworkopen.2025.27403","article-title":"Electronic patient-reported outcomes with vital sign monitoring during trastuzumab deruxtecan therapy: The PRO-DUCE randomized clinical trial","volume":"8","author":"Kikawa","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Stevens, S.X., El-Katateny, E., Gupta, A., De Abreu Louren\u00e7o, R., Shaw, J., Booth, C.M., and Vardy, J.L. (2026). Stakeholder Perspectives on the Term Time Toxicity to Describe Health Care Contact Time Associated With Cancer Treatments. JCO Oncol. Pract., Epub ahead of printing.","DOI":"10.1200\/OP-25-00898"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/8\/1551\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T04:11:08Z","timestamp":1786680668000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/8\/1551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":89,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["medicina62081551"],"URL":"https:\/\/doi.org\/10.3390\/medicina62081551","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]}}}